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Abstract
Introduction: The adrenocortical rest tumours are the very rare entity in the pediatric population. They are usually
found along the gonadal descent paths (celiac axis, the broad ligamen, the adnexa of the testes or the spermatic
cord). They have been also described to occur at rare ectopic sites like intracranial locations, placenta, kidney,
pancreas and liver.
Clinical case: Here we present a unusual case of an ectopic, virilising, primary adrenocortical tumour localized in
the spinal region in a 8 years-old-boy.
Discussion: This is the first case of functional ectopic, adrenocortical tumour localized in the spinal region in a
pediatric population. We discuss here the clinical presentation and the diagnostic challenges and provide the
review of the literature.
Case Report
A 7.5-year-old boy presented to the Department of
Endocrinology with symptoms of virilisation (presence
of pubic hair, enlargement of penis), acne and adult body
odour.
Our patient was born after a full-term, unremarkable
pregnancy and exhibited normal development until the
age of 5 years. At the age of 5.5 years, the first symptoms
of virilisation started to appear (pubic hair and enlarge-
ment of penis) as well as acceleration of growth velocity.
On admission to the Endocrinology Department, on
physical examination the patient was found to have
pubic hair (Tanner stage III/IV), a large penis measuring
around 6 cm. His height was 144 cm (+3.25SD) with a
weight 28.1 kg (5–10 centile according to the height) , a
growth spurt was diagnosed (growth velocity 9 cm/year),
his bone age was two years advanced. There was acne
limited to the region of his face and adult body odour
but no axillary hair and no striae. Testicular size (2 ml
each) and structure were normal for age. Moreover,
neurologic examination revealed that the patient had dif-
ficulty in walking (he walked on his toes), increased leg
reflexes and right site foot-clonus. His bowel and blad-
der function were normal as well his sensation.
Laboratory investigations revealed significantly raised
serum androgen levels (Table 1), abnormally high con-
centrations of androgen metabolites in the urine steroid
profile that were suggestive of a virilising tumour; and
normal cortisol and ACTH levels.
There was no androgen suppression observed during
the 4-day Dexamethasone test (2 days of 2 mg/d, 2 days
of 8 mg/d) but normal cortisol suppression after the
small dose of Dexamethasone. Urine catecholamine and
their metabolites levels were normal.
The abdominal and thoracic computed tomography (CT)
scan and the adrenal magnetic resonance imaging (MRI)
revealed no abnormalities. The ultrasound of the testes was
normal. Adrenal scintigraphy (131 J-norcholesterol) showed
no adrenal autonomic function.
The brain MRI was normal, however spinal MRI T2-
and contrast enhanced T1-weighted images demonstrated
an ovoid, well-circumscribed, intradural extramedullary
enhancing mass measuring approximately 2.8x2.1x6.0 cm
(Fig. 1). The mass occupied the entire cross-section of the
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spinal canal at levels L3 to L4/5 (Fig. 2). The presence of
myxopapillary ependymoma was suspected.
The patient underwent an L3-L4 laminectomy. Upon
opening the dura, an extramedullary mass was seen.
There were calcifications within the arachnoid. The
white-grayish mass measured 3.0x2.0x5.0 cm, appeared
well-circumscribed, and showed no invasion of sur-
rounding tissues. The lesion was resected totally.
Microscopically features were of benign ectopic adre-
nocortical tumour (Fig. 3). On the IHCM (immunohisto-
chemistry and microscopy) panel the cells were positive
for melan-A, locally positive for synaptophisin and for
CD56. The cells were negative for glial fibrillary acidic
protein (GFAP), cytokeratins AE1/AE3 and chromogra-
nin. The proliferative activity ki67 index was low (locally
up to 3 %).
Postoperative course was uneventful apart from transi-
ent urinary bladder function disturbances (difficulty
urinating and patient required catheterisation regimen
for several weeks). The patient was followed up and the
normalization of androgen levels was observed in tests
performed 9 days, 2 and 7 months after surgery (Table 1).
Neurologic examination at 9 month post surgery was
normal apart from lack of right Achilles tendon reflex.
There were no abnormalities on control MRI of the
brain and spine performed 9 months post surgery. Un-
fortunately secondary to the endocrine activity of the
tumour, central precocious puberty occurred and patient
started the treatment with long acting LH-RH analogue.
The boy is now 10 years of age, his height is 162 cm and
bone age is three years advanced. Fig. 4 shows his
growth chart with final height prediction (the prediction
was based on his height, bone age and parental heights) [1].
Discussion
Adrenocortical tumours (ACT) are rare in children. It is
estimated that there are 19–20 new cases of adrenocorti-
cal carcinoma in children and adolescents per year in the
United States according to the Surveillance, Epidemiology
and End Results Program (http://seer.cancer.gov/). There
















472 381.6 173.0 66.2 13.0 2.07 2.56
following surgery
9 days 154 36.1 13.4 37.6 12.2
2 months 111 59.9 31.3 51.3 17.9 3.15 4.6
7 months 110 64 51.7 28.3 15.2 46a 12.5a
In bold are the values that are above the normal values
aThe values following the LH-RH stimulation test
Fig. 1 MRI of the spine. Sagittal contrast enhanced T1- weighted
image shows a well-circumscribed, ovoid, strong enhancing intradural
extramedullary mass at the L3-L4/5 level
Fig. 2 MRI of the spine. Axial T1-weighted post-contrast injection
image: the mass occupies the entire cross-section of the spinal canal
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is a peak incidence before four years of age (0.4 cases per
million) which then declines during the subsequent ten
years. The incidence then rises to 0.2 per million during
the late teens. The majority (60 %) of pediatric adrenocor-
tical tumours occur in children less than five years [2].
There is a female predominance but only prior to adoles-
cence (F/M 2:1 in young children, F/M 1:1 in adolescence)
[3]. The most common presentation is virilisation,
followed by hypercortisolism and hyperaldosteronism [4].
In adults there is predominance of non-hormone secreting
tumours.
Adrenal rest tumours (ART) are collection of adrenal
tissue that are found outside of the adrenal gland. The
aberrant adrenal tissues are divided into heterotopia and
the accessory adrenal gland. The former is derived from
adrenal primordium that has migrated at an embryonic
stage from neighboring organs such as kidneys or the
liver; whereas the latter is the ectopia of fragmented ad-
renal tissues into the celiac axis, retroperitoneal cavity,
uterus, broad ligament or testis [5].
Fig. 3 Histopathology of ectopic adrenocortical tumour in the spinal
region. Hematoxylin and eosin stain, original magnification 200x. The
tumour is comprised of round and polygonal cells with abundant
eosinophilic cytoplasm
Fig. 4 Growth chart of our patient. The figure shows his growth, his final height prediction that is based on his height, bone age and parental
height. Also the curve of his height velocity and the age of predicted peak height velocity is indicated
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Ectopic adrenocortical tumour in the region of the
spinal cord is a very rare phenomenon [6,7]. It is very
difficult to explain the pathogenesis of intradural spinal
adrenal tissue. Karikari et al. speculated that premature
separation of ectoderm from neuroectoderm before neu-
rulation is completed may permit invasion of the neural
groove by mesoderm tissue that is committed to the for-
mation of adrenocortical tissue [8]. Whereas in cases
with extramedullary adrenocortical tumours it has been
suggested that ectopic rests of adrenal cells may gain ac-
cess into the spinal canal via the sheath of an existing
nerve or along the adventitia of an in-growing segmental
lumbar artery from the aorta [6].
So far there have been only 6 cases of ARTs localized
in the spinal region reported in the literature (Table 2).
Those tumours occurred in the lower spinal region at
a median patient age of 22 years (5 months to 63 years)
and with a notable female predominance (5:1). In 2004
Cassarino reported the first case of an ACT within the
CNS in a male patient [9]. This was also the first case of
an intramedullary involvement. All of the tumours did
not show atypia nor recurrence. In 2009 Rodriguez re-
ported the first case of a tumour in a very young girl
(5 months old) in whom although gross total resection
was performed, 6 months later the lesion recurred [10].
It is difficult to separate benign from malignant tu-
mours. There is no single criterion and histopathological
classification may not be reliable. Recently several, mo-
lecular markers have been investigated as a diagnostic
aid: overexpression of IGF-2, IGF-1R, somatic p53 muta-
tions, ki67 index and loss of heterozygosity of 11q13
[11–14]. Morphological signs of tumour carcinogenic
potential is tumour weigh (>100 g) and diameter
(>5 cm)[15].
All reported, up till now, tumours in the spinal region
were non functional. In the literature there were only
few cases of clinically-functioning adrenal rest tumours
[16] but all of them were localized outside the central
nervous system. None of the cases reported so far noted
signs of clinical virilisation/feminisation, Cushingoid fea-
tures or abnormal serum cortical levels.
In the present study, the young boy exhibited typical
symptoms of virilizing tumour with high serum levels
of androgens and characteristic urine steroid profile,
normal cortisol circadian rhythm and normal sup-
pressed serum cortisol level following Dexametasone
administration.
His clinical signs were pubic hair, enlargement of
penis, growth acceleration, adult body odour, acne. We
encountered difficulty in localization the tumour. Nei-
ther ultrasonography, CT or scintigraphy did not reveal
the tumour and as well as brain MRI were all normal.
Definite diagnosis was made with MRI of the spine. The
diagnosis was of a benign adrenal tumour. Vascular inva-
sion and metastasis were not found.
Considering the final, adult height prediction in chil-
dren with advance bone age due to hypersecretion of
androgens, it is reported in the literature, that early rec-
ognition and treatment can normalize the growth pat-
tern [17]. Although in our case the central precocious
puberty has led to further advancement of the bone age,
the boy’s predicted height based on his actual height, ad-
vanced bone age and parental heights does not differ
much from the target height.
In summary we report the unique occurrence of a pri-
mary adrenocortical tumour in the spinal region of a
young boy. To the best of our knowledge this is the first
report of a ACT with the steroidogenic capacity within
that localization. Although the occurrence of adrenocor-
tical tumours in central nervous system is rare, patholo-
gist should be aware that ectopic tumours both benign
and malignant that may arise at this localization. Even in
cases with no frank histological malignancy features
present the patient should be followed-up.
Consent
Written informed consent was obtained from the pa-
tient’s parents/legal guardians for publication of this case
Table 2 Intraspinal adrenal cortical adenomas reported in the literature
Ref. No. Age (yr)/sex Lesion location Symptoms Outcome
Kepes et al., 1990 [7] 8/F Extramedullary, cauda eqina at L2 Bilateral leg pain behind the knees Complete resection
Mitchell et al., 1993 [8] 16/F Extramedullary adherent to L2
sensory nerve root
Pain in posterolateral right thigh Complete resection
Mitchell et al., 1993 [8] 63/F Extramedullary at cauda eqina Lower back pain radiating to bilateral
lower extremities
Complete resection
Cassarino et al., 2004 [10] 27/M Intramedullary at conus medullaris Lower extremity weakness, spastic
paralysis, hypoesthesia below T10
Complete resection
Karikari et al., 2006 [9] 27/F Intramedullary at conus medullaris
with spinal dysraphism
Bilateral leg pain, urinary frequency Subtotal resection, Residual,
stable primary adrenal tumor
Rodriguez et al., 2009 [11] 5 mo/F Extramedullary at T10-L2 Inability to bear weigth in lower
extremity, irritability
Complete resection, recurrent
tumor at 6 mo, chemotherapy
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report and any accompanying images. A copy of the
written consent is available for the review by the Editor-
in-Chief of this journal.
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